Physician profile
Faisel M Zaman
NPI 1659330504
$3,643.04
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,136 · 2020: $245 · 2021: $208 · 2022: $54.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,006.13 | 2019-2020 | |
| Epimed International, INC | $207.87 | 2021 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Boston Scientific Corporation | $80.75 | 2019 | |
| Abbott Laboratories | $62.31 | 2019-2022 | |
| Bioventus LLC | $31.03 | 2020 | |
| Avanos Medical | $27.95 | 2019 | |
| Depuy Synthes Sales INC. | $17.34 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.23 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisel Zaman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.